HansBiomed Corporation (042520) — Capital Reinvestment Ratio
HansBiomed Corporation (042520) has a Capital Reinvestment Ratio of 0.37x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩1.21 Billion) in capital expenditures (₩448.85 Million). Check tangible equity quality of HansBiomed Corporation to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
HansBiomed Corporation Capital Reinvestment Ratio (2012–2025)
This chart tracks HansBiomed Corporation's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of HansBiomed Corporation.
Annual Capital Reinvestment Ratio for HansBiomed Corporation (2012–2025)
Year-by-year Capital Reinvestment Ratio for HansBiomed Corporation from 2012 to 2025. See 042520 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 5.52x | ₩318.34 Million | ₩1.76 Billion | ▲ +243.2% |
| 2024 | 1.61x | ₩1.76 Billion | ₩2.83 Billion | ▲ +31.3% |
| 2020 | 1.23x | ₩5.75 Billion | ₩7.05 Billion | ▼ -39.3% |
| 2019 | 2.02x | ₩7.71 Billion | ₩15.56 Billion | ▲ +368.7% |
| 2018 | 0.43x | ₩5.20 Billion | ₩2.24 Billion | ▼ -81.5% |
| 2017 | 2.33x | ₩5.60 Billion | ₩13.05 Billion | ▲ +33.1% |
| 2015 | 1.75x | ₩3.47 Billion | ₩6.07 Billion | ▼ -70.9% |
| 2014 | 6.01x | ₩2.06 Billion | ₩12.39 Billion | ▲ +92.3% |
| 2013 | 3.13x | ₩2.33 Billion | ₩7.29 Billion | ▲ +1750.5% |
| 2012 | 0.17x | ₩1.50 Billion | ₩253.56 Million | — |